Research Article
Evaluation of the Graves’ Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population
Table 1
Demographic and clinical data for Grave’s ophthalmopathy patients.
| | | % |
| Female/male | 58/30 | 65.9/34.1 | Age (y, mean ± SD, range) | 41.5 ± 15.6 (13–73) | | Duration of autoimmune thyroid diseases (months, mean ± SD, range) | 35.8 ± 52.3 (1–240) | | GO duration (months, mean ± SD, range) | 16.1 ± 23.7 (1–120) | | Clinical activity score | CAS < 3 (cases, %) | 78 | 88.6 | CAS ≥ 3 (cases, %) | 10 | 11.4 | Clinical severity | Mild | 30 | 34.1 | Moderate-severe | 37 | 42.1 | Sight-threatening | 21 | 23.9 | Diplopia/no diplopia | 36/52 | 40.9/59.1 | Proptosis (mm, mean ± SD, range) | 18.4 ± 2.9 (11–27) | |
|
|